Buell Jennifer insider trades
Buell Jennifer has filed 26 Form 4s with the SEC that we hold, for Agenus INC (AGEN) (See Remarks, Director), MiNK Therapeutics, Inc. (INKT) (Chief Executive Officer, Director) and Protagenic Therapeutics, Inc.\new (PTIX) (Director). Across all of them we count 0 purchases worth $0 and 1 sale worth $73.3K reported on Form 4. In the last 12 months: 0 purchases ($0) and 1 sale ($73.3K). The largest single trade was a sale of 6,938 shares of MiNK Therapeutics, Inc. worth $73.3K, dated 2026-10-12. Of 1 sale filed since we began reading the 10b5-1 checkbox, 0 (0%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2021-07-02 and the latest 2026-10-14.
Agenus INC (AGEN)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
MiNK Therapeutics, Inc. (INKT)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2026-10-12 | S, sale reported on Form 4 | 6,938 | $73.3K | 2026-10-14 | SEC |
Protagenic Therapeutics, Inc.\new (PTIX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1711184) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
